Search clinical trials for: Limited cancer screening FDG PET/CT

Total 350 results

University Hospital, Brest
Canadian Institutes of Health Research (CIHR); Ministry of Health, France; Ottawa...

Recruiting

Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism (MVTEP2/SOME2)

Embolism and Thrombosis

France, Canada
Washington University School of Medicine

Terminated

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

United States
University of Utah
National Cancer Institute (NCI)

Completed

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Venothromboembolism

United States
Peter MacCallum Cancer Centre, Australia
Melbourne Health; Westmead Hospital; Victorian Infectious Diseases Reference...

Completed

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia (PIPPIN)

Acute Myeloid Leukemia | Febrile Neutropenia | Acute Lymphoblastic Leukemia | Haematopoietic Stem Cell Transplant, Autologous | Haematopoietic Stem Cell Transplant, Allogeneic

Australia
Region Västerbotten
Umeå University

Recruiting

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) (PRODIGYN)

Cervix Cancer | Endometrial Cancer | Epithelial Ovarian Cancer

Sweden
Jewish General Hospital

Recruiting

FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis

Vasculitis | Giant Cell Arteritis

Canada
Institute of Oncology Ljubljana
University of Ljubljana

Unknown

FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy

Correlation of iRADIOMICS and irRC With Survival

Slovenia
Centre Hospitalier Universitaire Saint Pierre

Completed

PET/CT in Extrapulmonary TB in HIV Patients: a Clinical Trial

Extrapulmonary Tuberculosis in HIV Patients
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M) | Untreated Bone Metastases

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

FDG PET/CT in Lung Cancer Staging

Non-Small Cell Lung Cancer (NSCLC)

United States
University of Zurich

Withdrawn

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

Adenocarcinoma | Stomach Cancer | Cancer of Esophagogastric Junction

Switzerland
Rabin Medical Center

Unknown

Evaluation of PET CT in the Management of Patients With Crohn's Disease.

Crohn's Disease

Israel
Université de Sherbrooke

Unknown

Use of FDG PET/CT to Evaluate Crohn Disease

Crohn Disease

Canada
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Ontario Clinical Oncology Group (OCOG)
Cancer Care Ontario

Active, not recruiting

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging (PET MUSE)

Muscle-invasive Bladder Cancer

Canada
Herlev Hospital

Completed

Diagnostic Imaging of Myeloma Bone Lesions (RAMP)

Multiple Myeloma

Denmark
Ohio State University Comprehensive Cancer Center

Completed

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Pennsylvania

Completed

PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

United States
Odense University Hospital

Unknown

Dual PET/CT Imaging in Lung Cancer (DILUCE)

Lung Cancer

Denmark
Jules Bordet Institute

Completed

PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome. (earlyPETmCRC)

Colorectal Cancer Metastatic | Early Response Evaluation | Fdg-PET

Belgium
Jules Bordet Institute
Eli Lilly and Company

Completed

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (MiMe-A)

Cholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCC

France, Belgium
Odense University Hospital

Active, not recruiting

Molecular Evaluation in Metastatic Breast Cancer (MESTAR)

Metastatic Breast Cancer | Molecular Imaging

Denmark
University of Sao Paulo

Unknown

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Rectal Cancer

Brazil
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
Guangdong Provincial People's Hospital

Recruiting

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors (FAPI)

Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Mucinous Adenocarcinoma | Signet Ring Cell Carcinoma

China
The Greater Poland Cancer Centre

Active, not recruiting

HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy (HPV-RICCO)

Cervical Cancer

Poland
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Centre Georges Francois Leclerc

Recruiting

FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM) (MIM)

Multiple Myeloma

France
Institut Claudius Regaud

Completed

Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer (IQversusMI)

Cancer

France
Washington University School of Medicine

Recruiting

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

Cancer

United States
Guangdong Provincial People's Hospital
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Recruiting

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors (68Ga-GPFAPI)

Cancer | Metastatic Cancer | Malignant Neoplasm | Tumors

China
Academisch Ziekenhuis Maastricht

Recruiting

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Lymphoma | Lung Cancer

Netherlands
Montreal Heart Institute

Completed

PET-FDG in Myocarditis (PETMYO)

Myocarditis | Viral Myocarditis

Canada
University of Pennsylvania

Completed

Circadian Brown Adipose Tissue Metabolism

Healthy

United States
Peking Union Medical College Hospital

Active, not recruiting

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

Hepatocellular Carcinoma | Bile Duct Cancer

China
Odense University Hospital

Unknown

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer (Dual PETOvac)

Ovarian Cancer

Denmark
Asan Medical Center
Boryung Pharmaceutical Co., Ltd

Unknown

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
University of Pennsylvania

Active, not recruiting

FDG PET/CT in Breast Cancer Bone Mets

Bone Metastases | Estrogen Receptor Positive Breast Cancer

United States
European Organisation for Research and Treatment...
Polish Lymphoma Research Group

Withdrawn

Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) (H11)

Hodgkin Lymphoma

Denmark
Gert Meijer
M.D. Anderson Cancer Center

Completed

PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer (PRIOR)

Esophageal Cancer

United States, Netherlands
Michael C Roarke, MD

Completed

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

Multiple Myeloma

United States
Tel-Aviv Sourasky Medical Center

Unknown

FDG Metabolism in Dementia With Lewy Body (DLB) Patients as Indicated by PET Dynamic Acquisition

Dementia With Lewy Bodies
Ottawa Hospital Research Institute
Heart and Stroke Foundation of Canada; Brain Canada; Canadian Stroke Consortium...

Recruiting

Intensive Cancer Screening After Cryptogenic Stroke (INCOGNITO)

Occult Cancer

Canada
Central Hospital, Nancy, France

Not yet recruiting

Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease (FILM)

Crohn Disease
Centre Hospitalier Universitaire de Nice

Recruiting

Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy (TEP-ANTI-PD1)

Metastatic Melanoma

France
University of Utah
National Cancer Institute (NCI); MultiFunctional Imaging LLC

Recruiting

Dual-Tracer Theranostic PET

Prostate Cancer | Neuroendocrine Tumors

United States
University of Alabama at Birmingham

Recruiting

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
Johns Hopkins University
National Institutes of Health (NIH)

Recruiting

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

Invasive Fungal Infections | Inflammatory Disease | Oncologic Disease | Enterobacterial Infections

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

FDG-PET-CT and Biomarkers in Esophageal Cancer

Esophageal Cancer | Gastrointestinal Disease

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

Melanoma

United States

Search clinical trials for: Limited cancer screening FDG PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations